Thrombosis
From the Journals
LAA Closure noninferior to DOACs to prevent AF-related events
Left atrial appendage occlusion offers nondrug alternative to stroke prevention for atrial fibrillation patients.
Conference Coverage
TNF inhibitors cut odds of VTE in RA patients
Rather than increase risk for venous thromboembolism events, TNF inhibitors cut risk by nearly half, and other newer biologics lowered risk by...
News
Ticagrelor gets FDA nod for DAPT in high-risk patients with CAD
The new indication is based on THEMIS, which comprised patients with CAD and type 2 diabetes without previous MI or stroke and showed clinical...
Conference Coverage
Onyx stent meets DAPT performance goal in bleeding-risk patients
A zotarolimus-eluting coronary stent met its FDA-set performance goal in high-bleeding-risk patients on dual antiplatelet therapy for 1 month.
Guidelines
Societies offer advice on treating osteoporosis patients during pandemic
General and specific recommendations from leading bone health organizations shine a light on how to manage osteoporosis patients during the COVID-...
From the Journals
Evidence builds linking anticoagulation to COVID-19 survival
“Any family of mine who will have this disease absolutely will be on antithrombotic therapy and, actually, so are all of the patients at Mount...
News
COVID-19–associated coagulopathy
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
Conference Coverage
AUGUSTUS: After ACS or PCI, aspirin gives AFib patients scant benefit
Adding aspirin to an anticoagulant and P2Y12 inhibitor showed no net benefit, even acutely, suggesting need to target aspirin to highly selected...
From the Journals
ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients
News
Mislabeled clopidogrel lot recalled, may contain simvastatin
Conference Coverage
PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis